Two Sigma Advisers’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.82M | Buy |
809,200
+574,000
| +244% | +$2.71M | 0.01% | 838 |
|
|
2025
Q1 | $1.08M | Buy |
235,200
+78,900
| +50% | +$362K | ﹤0.01% | 1444 |
|
|
2024
Q4 | $749K | Buy |
156,300
+15,700
| +11% | +$75.2K | ﹤0.01% | 1600 |
|
|
2024
Q3 | $659K | Sell |
140,600
-73,500
| -34% | -$345K | ﹤0.01% | 1596 |
|
|
2024
Q2 | $1.21M | Sell |
214,100
-489,800
| -70% | -$2.77M | ﹤0.01% | 1456 |
|
|
2024
Q1 | $2.89M | Sell |
703,900
-182,600
| -21% | -$750K | 0.01% | 1033 |
|
|
2023
Q4 | $3.74M | Buy |
886,500
+118,200
| +15% | +$499K | 0.01% | 949 |
|
|
2023
Q3 | $3.32M | Buy |
768,300
+142,600
| +23% | +$616K | 0.01% | 924 |
|
|
2023
Q2 | $4.12M | Buy |
625,700
+48,300
| +8% | +$318K | 0.01% | 855 |
|
|
2023
Q1 | $3.92M | Buy |
577,400
+124,000
| +27% | +$842K | 0.01% | 926 |
|
|
2022
Q4 | $3.35M | Buy |
453,400
+15,600
| +4% | +$115K | 0.01% | 954 |
|
|
2022
Q3 | $4.33M | Sell |
437,800
-147,900
| -25% | -$1.46M | 0.01% | 803 |
|
|
2022
Q2 | $6.38M | Sell |
585,700
-300
| -0.1% | -$3.27K | 0.02% | 662 |
|
|
2022
Q1 | $6.63M | Buy |
586,000
+38,600
| +7% | +$437K | 0.02% | 682 |
|
|
2021
Q4 | $8.59M | Buy |
547,400
+159,100
| +41% | +$2.5M | 0.02% | 554 |
|
|
2021
Q3 | $6.66M | Sell |
388,300
-20,800
| -5% | -$356K | 0.02% | 663 |
|
|
2021
Q2 | $8.8M | Buy |
409,100
+83,800
| +26% | +$1.8M | 0.02% | 620 |
|
|
2021
Q1 | $4.89M | Buy |
325,300
+55,700
| +21% | +$837K | 0.01% | 862 |
|
|
2020
Q4 | $3.54M | Sell |
269,600
-42,200
| -14% | -$555K | 0.01% | 969 |
|
|
2020
Q3 | $3.01M | Sell |
311,800
-129,800
| -29% | -$1.25M | 0.01% | 959 |
|
|
2020
Q2 | $5.05M | Buy |
441,600
+24,400
| +6% | +$279K | 0.01% | 792 |
|
|
2020
Q1 | $4.32M | Buy |
417,200
+35,100
| +9% | +$364K | 0.02% | 763 |
|
|
2019
Q4 | $6.27M | Buy |
382,100
+4,200
| +1% | +$68.9K | 0.01% | 755 |
|
|
2019
Q3 | $5.02M | Sell |
377,900
-42,200
| -10% | -$560K | 0.01% | 759 |
|
|
2019
Q2 | $5.92M | Buy |
420,100
+118,600
| +39% | +$1.67M | 0.01% | 766 |
|
|
2019
Q1 | $5.55M | Buy |
301,500
+72,800
| +32% | +$1.34M | 0.01% | 804 |
|
|
2018
Q4 | $5.98M | Sell |
228,700
-43,300
| -16% | -$1.13M | 0.02% | 743 |
|
|
2018
Q3 | $6.24M | Sell |
272,000
-28,100
| -9% | -$645K | 0.02% | 740 |
|
|
2018
Q2 | $5.72M | Buy |
300,100
+162,600
| +118% | +$3.1M | 0.02% | 801 |
|
|
2018
Q1 | $2.32M | Buy |
137,500
+30,300
| +28% | +$511K | 0.01% | 1178 |
|
|
2017
Q4 | $1.63M | Sell |
107,200
-44,100
| -29% | -$670K | ﹤0.01% | 1334 |
|
|
2017
Q3 | $2.71M | Buy |
151,300
+4,200
| +3% | +$75.2K | 0.01% | 1065 |
|
|
2017
Q2 | $2.4M | Buy |
147,100
+32,800
| +29% | +$535K | 0.01% | 1113 |
|
|
2017
Q1 | $1.6M | Sell |
114,300
-46,500
| -29% | -$651K | 0.01% | 1372 |
|
|
2016
Q4 | $2.57M | Buy |
160,800
+31,900
| +25% | +$509K | 0.01% | 1055 |
|
|
2016
Q3 | $2.15M | Buy |
128,900
+73,800
| +134% | +$1.23M | 0.01% | 997 |
|
|
2016
Q2 | $617K | Buy |
+55,100
| New | +$617K | ﹤0.01% | 1419 |
|